Post-LASIK quality of life to be officially assessed

Article

A new study assessing the quality of life after LASIK is to be conducted by the American Society of Cataract and Refractive Surgery (ASCRS), the American Academy of Ophthalmology, the FDA and the National Eye Institute, it was announced at this year's ASCRS meeting in Chicago, US.

A new study assessing the quality of life after LASIK is to be conducted by the American Society of Cataract and Refractive Surgery (ASCRS), the American Academy of Ophthalmology, the FDA and the National Eye Institute, it was announced at this year's ASCRS meeting in Chicago, US.

The study is currently under evaluation but will be a large, multicentre, prospective study, assessing which factors contribute to satisfaction and dissatisfaction following surgery, and how quality of life is impacted. The goal of the study, which will not appraise the safety or efficacy of LASIK, is to increase patient satisfaction to ≥99%.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.